Literature DB >> 27502627

Cancer burden in four countries of the Middle East Cancer Consortium (Cyprus; Jordan; Israel; Izmir (Turkey)) with comparison to the United States surveillance; epidemiology and end results program.

Hoda Anton-Culver1, Jenny Chang2, Freddie Bray3, Ariana Znaor3, Lisa Stevens4, Sultan Eser5, Barbara Silverman6, Omar Nimri7, Pavlos Pavlou8, Haris Charalambous8, Anna Demetriou8, Kevin Ward9, Argyrios Ziogas2.   

Abstract

It is important that population-based cancer registries provide accurate and reliable data for public health purposes. These data are essential data for planning of cancer control and prevention. In this study, we examined cancer incidence rates (year 2005-2010) in four MECC registries (Cyprus, Jordan, Israel, Izmir (Turkey)) and compared with the rates in the US. The overall age-standardized incidence rates for males were highest in the US followed by Israeli Jews, Izmir (Turkey), Cyprus, Israeli Arabs, and lowest in Jordan. In women the rates of cancer of all sites were also highest in US women followed by Israeli Jews, Cyprus, Israeli Arabs, Izmir (Turkey), and lowest in Jordan. It is of interest that although site-specific cancer rates differ between the countries studied, prostate, lung and colorectal cancers are within the five most common cancers males in all countries studied. In females, breast colorectal and endometrium cancers are three of the five most common cancers in females in all countries studied. The results presented in this paper can have implications for opportunities in cancer control and prevention in these countries. Future studies on individual cancer sites with highest rates in these Countries are currently underway.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cancer burden; Cancer risk; Middle East; Population-based cancer registries; SEER

Mesh:

Year:  2016        PMID: 27502627     DOI: 10.1016/j.canep.2016.06.004

Source DB:  PubMed          Journal:  Cancer Epidemiol        ISSN: 1877-7821            Impact factor:   2.984


  7 in total

1.  Cancer risk in different generations of Middle Eastern immigrants to California, 1988-2013.

Authors:  Clara Ziadeh; Argyrios Ziogas; Hoda Anton-Culver
Journal:  Int J Cancer       Date:  2017-08-29       Impact factor: 7.396

Review 2.  Role of natural killer cells in lung cancer.

Authors:  Ozge Nur Aktaş; Ayşe Bilge Öztürk; Baran Erman; Suat Erus; Serhan Tanju; Şükrü Dilege
Journal:  J Cancer Res Clin Oncol       Date:  2018-04-03       Impact factor: 4.553

3.  The Epidemiology and Trend of Cancer in Jordan, 2000-2013.

Authors:  Yousef S Khader; Ghazi F Sharkas; Kamal H Arkoub; Mahmoud A Alfaqih; Omar F Nimri; Albaraa M Khader
Journal:  J Cancer Epidemiol       Date:  2018-10-17

4.  The Comparison of the Plasma Levels of the Lead Element in Patients with Gastrointestinal Cancers and Healthy Individuals.

Authors:  Masoudreza Sohrabi; Zahedine Kheiri; Ali Gholami; Mehran Haghighi; Fahimeh Safarnezhad Tameshkel; Mahmood Khoonsari; Majidreza Adelani; Amirhossein Mirhosseini; Melika Sohrabi; Azam Rezaei Farimani; Farhad Zamani; Hossein Ajdarkosh; Amir Hossein Faraji
Journal:  Asian Pac J Cancer Prev       Date:  2019-09-01

5.  Breast Cancer Knowledge, Attitudes and Practices amongst Women in Qatar.

Authors:  Ehab Hamed; Bayan Alemrayat; Mohamed Ahmed Syed; Suhad Daher-Nashif; Hadi Mohamad Abu Rasheed; Tanya Kane
Journal:  Int J Environ Res Public Health       Date:  2022-03-28       Impact factor: 3.390

6.  Palestinian Patients with Cancer at King Hussein Cancer Center.

Authors:  Razan Mansour; Justin Z Amarin; Abdallah Al-Ani; Maysa Al-Hussaini; Asem Mansour
Journal:  Front Oncol       Date:  2022-09-30       Impact factor: 5.738

7.  Regional Variation of Pancreatic Cancer Incidence in the Nile Delta Region of Egypt over a Twelve-Year Period.

Authors:  Christina Baum; Amr S Soliman; Heidi E Brown; Ibrahim A Seifeldin; Mohamed Ramadan; Breanne Lott; An Nguyen; Ahmed El-Ghawalby; Ahmed Hablas
Journal:  J Cancer Epidemiol       Date:  2020-07-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.